ENCERBA Trademark

Trademark Overview

On Monday, December 17, 2012, a trademark application was filed for ENCERBA with the United States Patent and Trademark Office. The USPTO has given the ENCERBA trademark a serial number of 85804280. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 8, 2016. This trademark is owned by Glaxo Group Limited. The ENCERBA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
encerba

General Information

Serial Number85804280
Word MarkENCERBA
Filing DateMonday, December 17, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 8, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ENCERBA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, August 8, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 8, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, December 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 17, 2015EXTENSION 5 GRANTED
Wednesday, December 9, 2015EXTENSION 5 FILED
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 22, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 9, 2015EXTENSION 4 GRANTED
Monday, June 1, 2015EXTENSION 4 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Thursday, December 11, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 10, 2014EXTENSION 3 GRANTED
Tuesday, December 2, 2014EXTENSION 3 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Saturday, July 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 18, 2014EXTENSION 2 GRANTED
Monday, June 23, 2014EXTENSION 2 FILED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2013EXTENSION 1 GRANTED
Monday, December 16, 2013EXTENSION 1 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 25, 2013ASSIGNED TO EXAMINER
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

encerba pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological